
|Articles|December 2, 2016
Rheumatoid Arthritis Biosimilar Development Highlights Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top news of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/rheumatoid-arthritis-biosimilar-development-highli" target="_blank">View the story "Rheumatoid Arthritis Biosimilar Development Highlights Week in Specialty Pharmacy" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1s and Muscle Loss: The Conversation Pharmacists Are Not Having, But Should Be
2
AHA/ACC CKM Guideline Formally Endorses GLP-1 Therapies for Kidney, Heart Protection
3
Ammoxetine: Emerging Data from a Phase 2 Antidepressant Trial
4
McKesson ideaShare 2026: Building Specialty and Infusion Capacity From the Ground Up
5





















































































































